Investorideas.com

Investorideas.com
Breaking News

Thursday, January 28, 2021

The #AIEYE #Podcast - #Medtech #Stocks: GBT Technologies' (OTC: $GTCH) CTO Discusses the Significance of FDA Approval for the #qTerm Human Vital Signs Device; #artificialintelligence

The #AIEYE #Podcast - #Medtech #Stocks: GBT Technologies' (OTC: $GTCH) CTO Discusses the Significance of FDA Approval for the #qTerm Human Vital Signs Device; #artificialintelligence

 

Point Roberts WA, Vancouver BC – January 28, 2021  – Investorideas.com (www.investorideas.com), a global investor news source covering Artificial Intelligence (AI) brings you today’s edition of The AI Eye, featuring technology company GBT Technologies Inc. (OTCPINK:GTCH).  

 

Listen to today’s podcast:

https://www.investorideas.com/Audio/Podcasts/2021/012521-GTCH-qTerm.mp3

 

Read this in full at   https://www.investorideas.com/news/2021/artificial-intelligence/01281GTCH-FDA-Approval-qTerm.asp

 

Hear the Ai Eye on Spotify  

 

GBT Technologies Inc. (OTC PINK:GTCH) recently announced that GBT Tokenize Corp, its joint venture, is now seeking approval for its qTerm human vital signs device with the United States Food and Drug Administration (FDA). In an interview with Investorideas.com, GBT’s CTO, Danny Rittman, explained that the rigour of the FDA approval process was necessary and beneficial to the product.

 

“We are expecting some improvements and modifications because during the process of the FDA approval – and with their own guidelines and standards – we may definitely need to do some,” he said. “That’s something we’re looking forward to, because that’s only going to make the device better, more accurate and more credentialed. The more credentials we get for the device, the better for us. That’s the plan.”

 

FDA approval will also grant the qTerm legitimacy in the eyes of consumers, Rittman explained in a recent press release:

 

“Another aspect is to gain potential customer's confidence and trust in the product's performance and accuracy. We plan to offer the technology for personal, hospital and clinical usage [in] seeking to comply with the industry's standards and regulations.”

 

Rittman clarified however, that approval from the FDA is not essential but rather that the company was pursuing it to expand future market opportunities.

 

“FDA approval is not a must for qTerm, we voluntarily do this certification in order to bring the device to a clinical level which can open a whole world of possibilities marketing wise (clinics, hospitals, etc…),” he said. “The device can be introduced to the market as is in many other wearables that are not defined as a “medical device”, if for ramification only.”

 

In its first release, the qTerm will boast the abilities to measure body temperature, blood oxygen level and heart rate. GBT Tokenize will subsequently add blood pressure to this and these functions will be accompanied by a smartphone app and web application that will keep a history for the user's records, providing a geographical proximity alert and record statistical data about the user's vitals.

 

 “In addition the device measures ambient temperatures to notify the user about an efficient measurement environment for accuracy purposes.” Rittman added.

 

While there are other mobile health detection devices out there, the qTerm is distinguished by its being powered by GBT’s AI technology. Rittman indicated in the press release:

 

“…we believe that its main advantage upon similar products is its Artificial Intelligence technology that offers advanced features like real-time health statistics, analytics, and monitoring.”

 

“The AI will basically collect the data, track it, keep a history and will alert personally, per person in case of abnormalities,” he said. “Assuming a person takes, on a daily basis, their blood pressure, oxygen level or heart rate … the AI engine will notice differences … and the user is going to get notifications.”

 

From the press release: “Early detection of potential health issues, based on vitals can be crucial and a life saver. Applying for an FDA clearance is a long process but we strongly believe it will bring our technology to the highest standards to be used by hospitals and individuals.”

 

Sam Mowers, Investorideas.com

 

Read and hear other editions of the AI  Eye

 

For a list of artificial intelligence stocks on Investorideas.com visit here

Investors can trade these stocks and other ideas on our site using our  list of top stock trading apps including Robinhood , Acorn, Stash  and others.

About GBT Technologies Inc.

GBT Technologies Inc. (OTC PINK: GTCH) (“GBT”) (http://gbtti.com) is a development-stage company which considers itself a native IoT creator, developing Internet of Things (IoT) and Artificial Intelligence (AI) enabled mobile technology platforms.  GBT has a portfolio of Intellectual Property that, when commercialized, will include smart microchips, mobile and security applications and protocols, and supporting cloud software.  GBT’s system envisions the creation of a global mesh network.  The core of the system will be its advanced microchip technology that can be installed in any mobile or fixed device worldwide. GBT envisions this system as a low-cost, secure, private mesh network between any enabled devices, providing shared processing, advanced mobile database management/sharing and enhanced mobile features as an alternative to traditional carrier services.

 

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

The Investorideas.com podcasts are also available on iTunes,  Spotify, Tunein, Stitcher, Spreaker.com, iHeartRadio and Google Play Music.

 

Visit the Podcast page at Investorideas.com:

https://www.investorideas.com/Audio/

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com 

Disclosure: GTCH is a paid for featured AI stock on Investorideas.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

The AI Eye-  Watching stock news, deal tracker and  advancements in artificial intelligence is an original content brand of Investorideas.com

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android 

Join our Investor Club https://www.investorideas.com/membership/

 

Contact Investorideas.com

800 665 0411

 


Get more Technology stock investor ideas - news, articles, podcasts and stock directories

 

The #Hydrogen #Stocks Boom - Leaders in Hydrogen Talk about the Future Hydrogen Potential - $DYA.TO $DYFSF $BLDP $BLDP.TO $MOVE.C $MOTNF $XBC.TO $XEBEF @dynaCERT @BallardPwr @XebecInc

The #Hydrogen #Stocks Boom - Leaders in Hydrogen Talk about the Future Hydrogen Potential - $DYA.TO $DYFSF $BLDP $BLDP.TO $MOVE.C $MOTNF $XBC.TO $XEBEF @dynaCERT @BallardPwr @XebecInc

 

dynaCERT Inc. (TSX: $DYA.TO) (OTCQX: $DYFSF) (FRA: DMJ), Ballard Power Systems (NASDAQ: $BLDP) (TSX: $BLDP.TO), Clean Power (CSE: $MOVE.C) (OTC: $MOTNF) and Xebec Adsorption Inc. (TSX: $XBC.TO) (OTCQX: $XEBEF) share insights

 

Point Roberts WA, Delta BC, January 28, 2021 – Investorideas.com, a global news source and leading investor resource covering cleantech and renewable energy stocks (Renewableenergystocks.com) issue a sector snapshot featuring comments and insights from leaders in Hydrogen Tech discussing the future of a Hydrogen economy.

 

Read this article featuring dynaCERT in full at https://www.investorideas.com/news/2021/cleantech-climatechange/01281Hydrogen.asp

 

Management of Canadian-listed Hydrogen Tech stocks dynaCERT Inc. (TSX:DYA.TO) (OTCQX: DYFSF) (FRA:DMJ), Ballard Power Systems (NASDAQ: BLDP) (TSX: BLDP), Clean Power (CSE: MOVE) (OTC: MOTNF) and Xebec Adsorption Inc. (TSX: XBC) (OTCQX:XEBEF)  share their insights.

 

The Canadian government released its Hydrogen strategy for a global hydrogen market that will be worth $12 trillion by 2050 stating, “Hydrogen might be nature’s smallest molecule but its potential is enormous. It provides new markets for our conventional energy resources, and holds the potential to decarbonize many sectors of our economy, including resource extraction, freight, transportation, power generation, manufacturing, and the production of steel and cement.”

 

Jim Payne, President & CEO of dynaCERT Inc. (TSX: DYA.TO) (OTCQX: DYFSF) (FRA: DMJ) in a recent podcast interview with Investor Ideas notes, “We firmly believe that with the 16 years of experience and the engineering, research and development, it puts in the perfect vision to take advantage of the hydrogen economy. I have believed for a long time that the hydrogen economy was huge and it appears that the world is just now waking up to that reality again. The technology we have today is a bridge to that hydrogen economy that we're going to continue to expand and grow because it has now gained worldwide recognition within the hydrogen field.”

 

dynaCERT’s patented HydraGEN™ Technology creates hydrogen and oxygen on-demand through a unique electrolysis system and supplies these gases through the air intake to enhance combustion, resulting in lower carbon emissions and greater fuel efficiency.

 

Payne also went on to say, “I have always believed in collective intelligence and when I look at the team that we've got today at dynaCERT, I really do think we are very well positioned to continue on this road and to grow in this hydrogen economy. It's thrilling for me, and I certainly believe that that the carbon credit world is huge. I don't think there's a company out there that's better positioned to be able to take advantage of that. The more I look at the way things are changing with governments, I really do not believe that dynaCERT could possibly be at a better place in a better time than what it is today.”

 

Listen to the recent dynaCERT Podcast:

https://www.investorideas.com/Audio/Podcasts/2020/123020-dynaCERT.mp3

 

Talking about the government’s strategy, CEO of Clean Power, Mr. Joel Dumaresq (CSE: MOVE) (OTC: MOTNF) issued a press release in December and talked to Investor Ideas in a recent podcast about their plans vision for a hydrogen economy.

 

Dumaresq told Investor Ideas, “Clean Power is focused on alternative energy. Under Canadian securities laws we're qualified as a investment issuer. The hydrogen opportunity PowerTap Hydrogen (90% owned by Clean Power Capital Corp.) in California, is one acquisition in what we expect will be several in the clean energy sector.”

 

“The reason we made the investment was that we were intrigued by the fact that both here in Canada and south of the border in the US, there's a lack of hydrogen infrastructure. The ability to fuel with hydrogen, we have some great solutions, many of which were developed here in Canada. Vancouver's very own Ballard Power is one with hydrogen powered buses. But there's been an absence of infrastructure across North America for these vehicles. So the company that we acquired, PowerTap, produces a system that can go into virtually any fuel station; any  typical  gas station. We can actually produce hydrogen right on site and then enable the fueling of vehicles whether it be hydrogen powered trucks or buses or cars.”

 

Continued: “Where we see it migrating is, that we see an opportunity not only south of the border but particularly here in Canada, based on the fact that in Canada we have long distances between cities and areas of population. Therefore, hydrogen is much better suited than electricity in those applications because you can stop and fuel up and then carry on with your journey. We see this particularly with things like long haul trucking and buses that are moving across the prairie areas.  For long distances hydrogen makes a lot of sense. So what we're playing to is the $1.5 billion the Canadian government has earmarked for hydrogen infrastructure.”

 

Listen to the podcast with CEO of Clean Power, Mr. Joel Dumaresq

https://www.investorideas.com/Audio/Podcasts/2021/012521-Clean-Power-CEO.mp3

 

CEO Randall MacEwen of Ballard Power Systems (NASDAQ: BLDP) (TSX: BLDP) commented on green hydrogen’s future in a November Q3 Conference call, ”I do believe that longer term, you will see - first of all, you've got companies like Toyota and Hyundai, that are head down and committed to fuel cell passenger cars, and I don't see that changing. They're making very significant - continue to make very significant investments. You will see others, I believe, revisiting fuel cells in a couple of years as their prioritization in developing battery electric technology and platforms get scaled out and rolled out. A lot of them have struggled with that and are probably a little bit behind on some of those. So we'll see them coming back, particularly as vehicles enter a new environment where you have high utilization. And I think the -- if you look at the McKinsey report that was prepared for the Hydrogen Council in January and where they looked at the value proposition for fuel cell electric vehicles in the passenger car segments, there are a number of segments long-term where you see high utilizations, whether it's corporate fleets, taxis, and of course, shared mobility platforms. And when you layer on top of that autonomous drive vehicles, where not only do you have high utilization, but high energy requirements on board we think fuel cells will offer a compelling solution long term.”

 

Continued: “And I think importantly, what we're seeing is massive investment, hundreds of billions of dollars of investment, being dedicated for green hydrogen production. And once that's up, and you have electrolyzer scale down in cost and green hydrogen at a very attractive cost point, the passenger vehicle market comes squarely back into the opportunity set.”

 

Xebec Adsorption Inc.’s (TSX: XBC) (OTCQX:XEBEF) acquisition of HyGear positions Xebec to execute and accelerate its distributed renewable gas strategy. The acquisition of new hydrogen technology and access to new markets will enable Xebec to launch a commercially viable green hydrogen product offering.

 

In the November Q3 Conference call, Kurt Sorschak, Chairman, CEO and President of Xebec Adsorption Inc. said, “We continue to execute on sales and order intake. There are a number of new and exciting projects we are expecting in the short term both on the RNG and hydrogen side. These projects will add positively to the backlog and solidify our 2021 revenue targets.”

 

Continued: “I am excited to be announcing the launch of our hydrogen strategy today with this transformative acquisition. HyGear is strategic in nature and gives us an enormous amount of potential to grow as we accelerate our entry into the industrial hydrogen and hydrogen fuel markets, I couldn’t be happier with the quality of this acquisition because of its sustainable business model and its ability to deliver attractive profitability today. HyGear will help us execute our renewable gas strategy and gives us a unique technology platform, access to European markets and the potential to realize and create significant product and sales synergies.”

 

Continued: “Ultimately, we believe that hydrogen will be the dominant gas and energy carrier of the future. HyGear has built an outstanding business by first selling to industrial customers and then using the same technology to deliver solutions to the nascent hydrogen refueling industry. Their steam methane reforming (SMR) technology is unique in the sense that it is decentralized, small-scale and can produce cost-effective onsite hydrogen from natural gas. HyGear reduces the need to truck in hydrogen by producing it at the source of use, saving on costs, and most importantly, CO2 and NOx emissions. This results in cost savings of approximately 40% to 75% per Nm3 of hydrogen delivered and an annual reduction of approximately 60,000 KG of CO2 emissions per system. Their reference base of 66 active hydrogen generation installations worldwide is impressive and makes them the world leader.”

 

The Canadian government’s Hydrogen strategy also reports, “If Canada fully seizes the opportunity presented by hydrogen, it could lead to more than 350,000 sector jobs and direct revenues of over $50B/year by 2050.”

 

For investors following renewable energy and hydrogen stocks, visit the directory of publicly traded stocks https://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp

 

Visit the Cleantech and Climate Change Podcast page at Investorideas.com

 

About Investorideas.com - News that Inspires Big Investing Ideas Investorideas.com is a recognized news source publishing third party news, research and original financial content. Learn about investing in stocks and sector trends with our news alerts, articles, podcasts and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech, water, renewable energy and more. Investor Idea’s original branded content includes the following podcasts and columns : Crypto Corner , Play by Play sports and stock news column, Investor Ideas Potcasts Cannabis News and Stocks on the Move podcast and column,  Cleantech and Climate Change , Exploring Mining  the AI Eye .

 

Disclaimer/Disclosure: Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Contact management and IR of each company directly regarding specific questions. Disclosure: dynaCERT is a paid monthly news and publishing client on Investorideas.com. More disclaimer and disclosure info.  Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 

Follow us on Twitter https://twitter.com/Investorideas

Follow us on Facebook https://www.facebook.com/Investorideas

Follow us on YouTube https://www.youtube.com/c/Investorideas

Download our Mobile App for iPhone and Android  

 

Sign up for free stock news alerts at Investorideas.com

https://www.investorideas.com/Resources/Newsletter.asp

 

Contact Investorideas.com

800 665 0411

 

RenewableEnergyStocks.com: investing ideas in renewable energy stocks

Like Renewable Energy Stocks? View our Renewable Energy Stocks Directory

Get News Alerts on Renewable Energy Stocks

 

 

 

 

#AI #Health #Stock News: GBT Tokenize (OTCPINK: $GTCH) Engaged M Squared Associates to Support #FDA 510(k) Submission for qTerm; #Artificialintelligence

#AI #Health #Stock News: GBT Tokenize (OTCPINK: $GTCH) Engaged M Squared Associates to Support #FDA 510(k) Submission for qTerm; #Artificialintelligence

 


SAN DIEGO - January 28, 2021 (Investorideas.com Newswire) GBT Technologies Inc. (OTCPINK: GTCH) ("GBT", or the "Company") announced today that GBT Tokenize Corp ("GBT/Tokenize") engaged M Squared Associates (M2) to assist with developing the FDA premarket strategy for its qTerm device. For more than 20 years, M2 has been providing a full range of regulatory, quality and clinical consulting services to US and international medical technology firms. M2 specializes in devices, biologics and combination products that are reviewed by FDA's Center for Devices and Radiological Health (CDRH).

 

Read this news featuring GTCH in full at https://www.investorideas.com/CO/GOPH/news/2021/01281M-Squared-Associates.asp

 

The process of filing for FDA clearance involves development of a sound regulatory strategy for pathway to market, including required preclinical and performance testing, software verification and validation activities and ensuring user needs are met. In addition, GBT/tokenize will partner with M2 to finalize technical design documentation, device labeling claims and intended use. Other aspects that will be evaluated include manufacturing processes, usability / human factors and the development of valid scientific evidence. The company will work with M2 to develop a detailed description of the device’s software and algorithm training requirements, including design specifications. qTerm computer program will be reviewed for its control functions and other required performance testing plans and criteria according to FDA guidance documentation.

 

qTerm is a human vitals device that is aimed to measure human vitals with a touch of a finger. The device received its Trademark allowance notice and will present it on the product/package as required by the United States Patent Office ("USPTO"). qTerm device is designed to work with a smartphone app and web application that will keep a history for the user's records, provide a geographical proximity alert and record statistical data about the user's vitals. The device will be empowered by an AI system for data analytics, proximity alerts and personal health management. qTerm will also be evaluated to work within remote telemedicine infrastructure and therefore an extra attention will be done for its cybersecurity system.

 

"We would like to bring our qTerm device to the highest standards within this domain and FDA clearance will demonstrate that the device is safe and effective for its intended use and confirm compliance with regulations and guidelines. Our objectives are to assure qTerm’s credibility as part of our plans for national commercialization. The technology is intended for personal and clinical use and will also be evaluated for remote telemedicine operation.

Therefore, an extra focus will be on its cybersecurity system and protocol. FDA review process will include evaluation of hardware and software systems, including functional verification and validation testing performance data. A comprehensive assessment of risks, data analysis, and cybersecurity requirements will be conducted. In addition, a thorough review of its development environment, revision history, and unresolved anomalies will be done according to FDA guidelines. qTerm device is a non-invasive device to measure human vitals and includes an intelligent analytics system. The FDA submission process is involved, with complex regulatory challenges that are typically associated with advanced technologies and therefore we decided to hire experts in the field." Stated Danny Rittman, the Company’s CTO.

 

About Us

GBT Technologies, Inc. (OTC PINK: GTCH) ("GBT") (http://gbtti.com) is a development stage company which considers itself a native of Internet of Things (IoT), Artificial Intelligence (AI) and Enabled Mobile Technology Platforms used to increase IC performance. GBT has assembled a team with extensive technology expertise and is building an intellectual property portfolio consisting of many patents. GBT's mission, to license the technology and IP to synergetic partners in the areas of hardware and software. Once commercialized, it is GBT's goal to have a suite of products including smart microchips, AI, encryption, Blockchain, IC design, mobile security applications, database management protocols, with tracking and supporting cloud software (without the need for GPS). GBT envisions this system as a creation of a global mesh network using advanced nodes and super performing new generation IC technology. The core of the system will be its advanced microchip technology; technology that can be installed in any mobile or fixed device worldwide. GBT's vision is to produce this system as a low cost, secure, private-mesh-network between any and all enabled devices. Thus, providing shared processing, advanced mobile database management and sharing while using these enhanced mobile features as an alternative to traditional carrier services.

 

Forward-Looking Statements

Certain statements contained in this press release may constitute "forward-looking statements". Forward-looking statements provide current expectations of future events based on certain assumptions and include any statement that does not directly relate to any historical or current fact. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors as disclosed in our filings with the Securities and Exchange Commission located at their website (http://www.sec.gov). In addition to these factors, actual future performance, outcomes, and results may differ materially because of more general factors including (without limitation) general industry and market conditions and growth rates, economic conditions, governmental and public policy changes, the Company's ability to raise capital on acceptable terms, if at all, the Company's successful development of its products and the integration into its existing products and the commercial acceptance of the Company's products. The forward-looking statements included in this press release represent the Company's views as of the date of this press release and these views could change. However, while the Company may elect to update these forward-looking statements at some point in the future, the Company specifically disclaims any obligation to do so. These forward-looking statements should not be relied upon as representing the Company's views as of any date subsequent to the date of the press release.

 

Contact:

Dr. Danny Rittman, CTO
press@gopherprotocol.com

 

GBT Technologies Inc. (OTCQB:GTCH) is a featured tech stock on

Investorideas.com

 

More info on GTCH at Investorideas.com Visit: https://www.investorideas.com/CO/GOPH/

 

Get News Alerts on GBT Technologies Inc GTCH

 

Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news, articles and equity research as well as creates original content, including video, interviews and articles. Original content created by investorideas is protected by copyright laws other than syndication rights. Our site does not make recommendations for purchases or sale of stocks, services or products. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All investing involves risk and possible losses. This site is currently compensated for news publication and distribution, social media and marketing, content creation and more. Disclosure is posted for each compensated news release, content published /created if required but otherwise the news was not compensated for and was published for the sole interest of our readers and followers. Disclosure: GTCH is a PR, social media and publishing client and compensates Investorideas.com https://www.investorideas.com/About/News/Clientspecifics.asp

Contact management and IR of each company directly regarding specific questions.

More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com

Global investors must adhere to regulations of each country. Please read Investorideas.com privacy policy: https://www.investorideas.com/About/Private_Policy.asp

 


  Get more tech stocks investor ideas- news, articles, podcasts and stock directories